SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-009976
Filing Date
2021-08-03
Accepted
2021-08-03 16:03:50
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20210630x10q.htm   iXBRL 10-Q 2448426
2 EX-10.1 rigl-20210630xex10d1.htm EX-10.1 178604
3 EX-10.2 rigl-20210630xex10d2.htm EX-10.2 59877
4 EX-31.1 rigl-20210630xex31d1.htm EX-31.1 16163
5 EX-31.2 rigl-20210630xex31d2.htm EX-31.2 16884
6 EX-32.1 rigl-20210630xex32d1.htm EX-32.1 8769
7 GRAPHIC rigl-20210630x10q004.jpg GRAPHIC 148507
  Complete submission text file 0001558370-21-009976.txt   9107752

Data Files

Seq Description Document Type Size
8 EX-101.SCH rigl-20210630.xsd EX-101.SCH 55316
9 EX-101.CAL rigl-20210630_cal.xml EX-101.CAL 51508
10 EX-101.DEF rigl-20210630_def.xml EX-101.DEF 182232
11 EX-101.LAB rigl-20210630_lab.xml EX-101.LAB 490048
12 EX-101.PRE rigl-20210630_pre.xml EX-101.PRE 340511
13 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20210630x10q_htm.xml XML 1550024
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 211139656
SIC: 2834 Pharmaceutical Preparations